ASLAN Pharmaceuticals Pte Ltd announced today the completion of a Series B financing raising US$22 million. The financing was led by Cenova Ventures and included other new investors Morningside Group and XinChen Ventures. Existing investors BioVeda Capital and Sagamore Bioventures also participated in the round.
Click here for the full press release.